Department of Clinical Medicine and Surgery, Endocrinology Unit, University of Naples "Federico II", 80131 Naples, Italy.
Department of Medicine, Operative Unit of Andrology and Medicine of Human Reproduction, University of Padova, 35128 Padova, Italy.
Nutrients. 2022 May 18;14(10):2103. doi: 10.3390/nu14102103.
During the last decades, the gut microbiota has gained much interest in relation to human health. Mounting evidence has shown a strict association between gut microbiota and obesity and its related diseases. Inflammation has been appointed as the driving force behind this association. Therefore, a better understanding of the mechanisms by which gut microbiota might influence inflammation in the host could pave for the identification of effective strategies to reduce inflammation-related diseases, such as obesity and obesity-related diseases. For this purpose, we carried out an extensive literature search for studies published in the English language during the last 10 years. Most relevant studies were used to provide a comprehensive view of all aspects related to the association of gut microbiota and low-grade inflammation with obesity. Accordingly, this narrative review reports the evidence on the key players supporting the role of gut microbiota in the modulation of inflammation in relation to obesity and its complications. Moreover, therapeutic approaches to reduce microbiota-related inflammation are discussed to provide potential targets for future research.
在过去的几十年中,肠道微生物群与人类健康的关系引起了广泛关注。越来越多的证据表明,肠道微生物群与肥胖及其相关疾病之间存在严格的关联。炎症被认为是这种关联的驱动力。因此,更好地了解肠道微生物群可能影响宿主炎症的机制,可以为确定有效策略来减少与肥胖和肥胖相关的疾病(如肥胖和肥胖相关疾病)相关的炎症铺平道路。为此,我们对过去 10 年发表的英文文献进行了广泛的文献检索。大多数相关研究被用来全面了解与肠道微生物群和低度炎症与肥胖相关的所有方面。因此,本叙述性综述报告了支持肠道微生物群在调节肥胖及其并发症相关炎症中的作用的关键因素的证据。此外,还讨论了减少微生物群相关炎症的治疗方法,以为未来的研究提供潜在的目标。